Font Size: a A A

Analysis And Optimization Of Financing Structure Of TJ Company

Posted on:2024-03-02Degree:MasterType:Thesis
Country:ChinaCandidate:Y Y QiaoFull Text:PDF
GTID:2569307130499844Subject:Business Administration
Abstract/Summary:PDF Full Text Request
The pharmaceutical industry is an important part of a country’s national economy and an important industry related to the national economy and people’s livelihood.Vigorously developing the pharmaceutical industry is not only of great significance for promoting the development of China’s medical and health undertakings and enhancing the health and well-being of the people,but also conducive to generating new impetus for economic development.With the introduction of various national medical reform policies and industrial promotion policies,the pharmaceutical industry can be described as challenges and opportunities coexist,and capital is the lifeblood of an enterprise’s survival and development,but also the key to the survival and development of an enterprise in the fierce market competition.In this context,this paper takes TJ Company,a large state-owned pharmaceutical enterprise,as the research object to study the optimization of its financing structure.This paper firstly introduces the research background and significance of this paper,and summarizes the research status at home and abroad,and expounds the sustainable growth theory,EVA/SGR matrix theory and other relevant theories and methods,which lays the foundation for the development of this paper.Then,it investigates the current financing situation of TJ Company by way of field interview,expounds the current financing structure of the company from the perspectives of internal financing and external financing,analyzes the financing environment of the company,and summarizes the existing problems.Finally,combined with the company’s strategic objectives,based on relevant concepts and theories,this paper looks at the problem from the perspective of dynamic development,divides the optimization of financing structure into short and medium term,and puts forward specific suggestions,which mainly include: enhancing the internal financing ability,reducing the asset-liability ratio,and actively developing diversified financing methods.In addition,in order to ensure the smooth implementation of the new financing structure,combined with the problems existing in the current financing structure of the company,also put forward relevant safeguard measures,including the establishment of a dynamic risk prevention system and improve the financing decision-making process.
Keywords/Search Tags:Pharmaceutical Industry, Financing Scheme Optimization, Analytic Hierarchy Process, EVA/SGR
PDF Full Text Request
Related items